These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29392313)

  • 1. A Biodegradable, Sustained-Released, Tacrolimus Microfilm Drug Delivery System for the Management of Allergic Conjunctivitis in a Mouse Model.
    Liu YC; Ng XW; Teo EPW; Ang HP; Lwin NC; Chan NSW; Venkatraman SS; Wong TT; Mehta JS
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):675-684. PubMed ID: 29392313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
    Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
    Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of subconjunctival biodegradable microfilms for sustained drug delivery to the anterior segment in a small animal model.
    Liu YC; Peng Y; Lwin NC; Wong TT; Venkatraman SS; Mehta JS
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2607-15. PubMed ID: 23518771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty model.
    Liu YC; Peng Y; Lwin NC; Venkatraman SS; Wong TT; Mehta JS
    PLoS One; 2013; 8(8):e70419. PubMed ID: 23940573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
    Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model.
    Barequet IS; Platner E; Sade K; Etkin S; Ziv H; Rosner M; Habot-Wilner Z
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1717-21. PubMed ID: 23553288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virus.
    Stebbins KJ; Broadhead AR; Musiyenko A; Barik S; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
    Int Arch Allergy Immunol; 2012; 157(3):259-68. PubMed ID: 22042170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
    Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
    Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of rAmb a 1-Loaded PLGA-PEG Nanoparticles in a Murine Model of Allergic Conjunctivitis.
    Cao H; Liu L; Wang J; Gong M; Yuan R; Lu J; Xiao X; Liu X
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163859
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of Tacrolimus loaded micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone).
    Wang Y; Wang C; Fu S; Liu Q; Dou D; Lv H; Fan M; Guo G; Luo F; Qian Z
    Int J Pharm; 2011 Apr; 407(1-2):184-9. PubMed ID: 21251958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery.
    Ang M; Yan P; Zhen M; Foo S; Venkatraman SS; Wong TT
    Curr Eye Res; 2011 Dec; 36(12):1123-8. PubMed ID: 22007761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subconjunctival injection of human umbilical cord mesenchymal stem cells alleviates experimental allergic conjunctivitis via regulating T cell response.
    Li D; Ou Q; Shen Q; Lu MM; Xu JY; Jin C; Gao F; Wang J; Zhang J; Zhang J; Li J; Lu L; Xu GT; Tian H
    Stem Cell Res Ther; 2023 Oct; 14(1):281. PubMed ID: 37784129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement.
    Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H; Miyazaki D
    Br J Ophthalmol; 2014 Aug; 98(8):1023-7. PubMed ID: 24695688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo release characteristics of Tacrolimus (FK506) from an episcleral drug-delivery implant.
    Mai S; Lin L; Yang W; Deng X; Xie Z; Zong Y; Li Y; Gao Q
    J Ocul Pharmacol Ther; 2014 Oct; 30(8):670-80. PubMed ID: 24933028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis.
    Shin JH; Park HR; Kim SW; Park CS; Cho JH; Park YJ; Kim SW
    Am J Rhinol Allergy; 2012; 26(2):e71-5. PubMed ID: 22487280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin treatment for allergic conjunctivitis in the experimental BALB/c model.
    Kocatürk T; Kocatürk O; Kaplan A; Meteoğlu I; Cakmak H; Dayanir V
    Ophthalmic Res; 2013; 50(1):65-71. PubMed ID: 23774193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.